A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 104.21
GOOG 768.79
MSFT 56.68
FB 123.94
BAC 14.49

Recently Added

TSRO 93.24
ADPT 44.57
VNQ 92.45
VLUE 64.42
VIG 85.15

Gaining Speed

VNQ 92.45
DGS 41.49
MOAT 34.36
BSV 81.10
IAU 13.02

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!